NCT03008551View on ClinicalTrials.gov

Empagliflozin vs Metformin in PCOS

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

April 2, 2018

Study Completion Date

April 2, 2018

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Empagliflozin

Each participant will receive empagliflozin 25mg daily for 3 months.

DRUG

Metformin

Each participant will receive metformin 1500mg daily for 3 months.

Trial Locations (1)

HU3 2RW

Michael White Centre for Diabetes and Endocrinology, Hull

All Listed Sponsors
lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT03008551 - Empagliflozin vs Metformin in PCOS | Biotech Hunter | Biotech Hunter